Effects of aspirin/dipyridamole [Aggrenox] and low-dose aspirin on platelet activity in patients after ischaemic stroke

Trial Profile

Effects of aspirin/dipyridamole [Aggrenox] and low-dose aspirin on platelet activity in patients after ischaemic stroke

Completed
Phase of Trial: Phase I

Latest Information Update: 05 Nov 2010

At a glance

  • Drugs Aspirin/dipyridamole (Primary) ; Aspirin
  • Indications Embolism and thrombosis; Stroke
  • Focus Pharmacodynamics
  • Acronyms AGATE
  • Most Recent Events

    • 05 Nov 2010 New trial record.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top